New Delhi, Dec 26 (IANS) 2025 has been a year of evidence-based growth, global leadership, and people-centric healthcare for the Ayush sector.
New Delhi, Dec 26 (IANS) A newly developed artificial intelligence (AI) model is highly accurate in predicting blood loss in patients undergoing high-volume cosmetic surgery procedures, such as liposuction, according to a study.
New Delhi, Dec 26 (IANS) The gold prices surged over 0.5 per cent to record highs on Friday, due to rising geopolitical tensions and expectations for more US rate cuts next year.
Mumbai, Dec 26 (IANS) The foreign investors’ inflows in the Indian domestic equities is bouncing back and the long-term outlook for markets is robust, a report showed on Friday.
Banaskantha, Dec 25 (IANS) The Central government’s women-centric welfare initiatives are giving rural women new wings of empowerment and self-reliance, with the Namo Drone Didi Yojana emerging as a transformative force at the grassroots.
New Delhi, Dec 25 (IANS) India’s food safety regulator has tightened the rules on what can be officially called “tea”, making it clear that only products made from the plant Camellia sinensis can use the word on their labels.
Ahmedabad, Dec 25 (IANS) Navi Mumbai International Airport (NMIA) began commercial operations on Thursday -- marking a major milestone for Mumbai’s aviation sector and India’s infrastructure growth.
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.
Amaravati, Dec 25 (IANS) Union Minister of Agriculture Shivraj Singh Chouhan stated that Andhra Pradesh is marching towards ‘Quantum Yug’ and expressed hope that Amaravati will emerge as a great capital city in future.
New Delhi, Dec 25 (IANS) Sun Pharma’s US arm, Taro Pharmaceutical Industries, has recalled more than 17,000 units of antifungal over manufacturing issues, the US Food and Drug Administration (USFDA) has said.
